CVE-2025-61940HIGH 8.8EPSS p20.3%

CVE-2025-61940CVE-2025-61940

Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

Scoring

CVSS 3.18.8 (HIGH)
VectorCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
EPSS0.29% probability of exploitation · percentile 20.3% · 2026-06-18T12:00:27Z
Published2025-12-02
Last modified2026-01-02

Underlying weaknesses· 1

CWE-603

References

  1. https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01

1

TypeTargetConfidenceTier
WeaknessUse of Client-Side Authenticationcwe-6030%live

Related by meaning· 6

Nearest entities by semantic similarity across the cs-graph corpus.

CVE
CVE-2025-62575
CVE
CVE-2025-24999
CVE
CVE-2025-46274
CVE
CVE-2025-49759
CVE
CVE-2025-49758
CVE
CVE-2026-21262
Sourced from NVD + FIRST.org EPSS. Curated for EU compliance use cases by Adam Lundqvist, Founder at SQUR.